The limited transcriptomic data we obtained from one KRAS-mutant URCC patient suggest that a subset of cases in this heterogeneous group may be related to KRAS-mutant PRCC, given the overlapping chromosomal abnormalities and similar cells of origin. Here, KRAS is linked to Unclassified Renal Cell Carcinoma.